Go to main page
Bioduro Go to mainpage

WEBINAR SPEAKERS

Michael Thompson

McMaster University – Associate Dean and Professor of Chemical Engineering

Presentation: Developments in Twin-Screw Granulation

Date: May 26th

Dr. Michael Thompson is a Professor of Chemical Engineering and Associate Dean of Engineering at
McMaster University in Canada. His research group looks at processes related to polymers or particulate
production, to develop new manufacturing solutions for the industries of polymer, food,
pharmaceutical, and energy.  The group at McMaster is one of the earliest research contributors to the
field, beginning back in 2008, and has been responsible for much of the screw design and wetting
practices used today.  The group enjoys close collaborations with a range of experts in the drug and
excipient community and remains committed to seeing broader deployment of twin-screw granulation
within the industry.

REGISTER NOW


Dr. Chad Brown

Merck – Executive Director and Global Head, Pharmaceutical Sciences

Presentation: Hot Melt Extrusion as a Key Enabler of Developing Products of
Low Solubility Compounds

Date: June 2nd

Chad Brown is the Executive Director and Global Head of the Merck Animal Health Pharmaceutical Sciences group located in Rahway, NJ, USA. His responsibilities include oversight of Formulation, Analytical and Packaging R&D from early discovery to commercial launch. Chad has 17 years of drug product development experience. He joined Merck in 2007 in the Merck Research Laboratories in Human Health and led the Oral Formulation Sciences and Technology group in Human Health. During this tenure, he became a subject matter expert in solid dispersion manufacturing, specifically hot melt extrusion and served on the board of The Society of Plastic Engineers Extrusion Division. He has been fortunate to be involved with several publications, patents and product launches using this technology. Chad holds a PhD from the University of Washington in Bioengineering and a BS degree from Colorado State University in Chemical Engineering.

REGISTER NOW


Andy Birkmire

GEA – Process Development Manager

Presentation: Successful Strategies for Developing a Continuous Manufacturing Process

Date: June 9th

Andrew Birkmire is the Process Development Manager for GEA Process Engineering, Inc., a world leader in Pharmaceutical manufacturing technology. He has more than 20 years of experience with Pharmaceutical Batch and Continuous processes, including feeding, blending, granulation, drying, and coating. He currently runs the Pharmaceutical Technology Center in Columbia, MD.

REGISTER NOW


Dr. John Vrettos

Enteris BioPharma – Principal Scientist in Formulation Development

Presentation: Breaking Through the Barriers of Oral Biologics

Date: June 16th

Dr. John Vrettos joined Enteris BioPharma in July 2013 as a Principal Scientist in Formulation Development. He is responsible for development programs for the oral delivery of peptides and poorly-permeable small molecules from feasibility through clinical trials. Previously, Dr. Vrettos was with Unigene Laboratories, advancing formulations to enable the oral delivery of peptides. Dr. Vrettos gained much experience with solid oral formulation development while a Principal Scientist in Technical R&D at Novartis Pharmaceuticals from 2008 to 2012. Prior to that, he was a Senior Scientist in the Pharmaceutical Sciences department at Human Genome Sciences. Dr. Vrettos received his Ph.D. in biophysical chemistry from Yale University in 2001 and was a National Research Council Postdoctoral Fellow at NIST in the Biomolecular Materials group from 2002-2003.

REGISTER NOW


Dr. Harsh Chauhan

Creighton University – Associate Professor, Pharmacy

Presentation: Formulation Considerations for development of Ternary Solid Dispersions

Date: June 23rd

Dr. Chauhan is an Associate Professor in Pharmaceutical Sciences at Creighton University, NE, USA; with a research lab working in the area of developing novel drug delivery systems for poorly soluble compounds. He completed his PhD from MCPHS University, Boston, MA. He had published more than 25 peer reviewed article, five book chapters and presented around 50 posters in national and international conferences. He serves as reviewer and editorial board in many reputed pharmacy journals. He is a member of American Association of Pharmaceutical Scientist (AAPS) and American Chemical Society (ACS). His profile can be found here.

REGISTER NOW


Dr. Daniel Treffer

Melt Prep – CEO and Founder

Presentation: Rapid and lossless prototyping of HME formulations in the milligram to gram scale via Vacuum Compression Molding

Date: June 30th

Daniel Treffer is the founder and CEO of MeltPrep GmbH. A start-up company founded in 2016 which develops equipment for sample preparation. The company is based on his findings, which he obtained during his PhD in the field of pharmaceutical engineering. His work was supervised by Professor Khinast at the RCPE in Graz, where he faced several challenges in hot-melt extrusion development projects and recognised the strong need for novel tools for faster and lossless drug formulation developments. He patented the innovative vacuum compression molding (VCM) technology in 2014.
He also established two new product lines within his company. First, the VChamber, which turns any hot plate into a vacuum oven, and second ExtruVis, a technology for straight-forward and precise residence time distribution measurement.

During his career, Daniel has authored & published several scientific papers, contributed to the scientific textbook “Melt Extrusion by Dr. Repka” and is a coveted speaker at different conference talks all over the world.

His mission is to simplify drug development processes in order to enable pharma companies to bring much-needed drugs to the market as fast as possible.

REGISTER NOW


Dr. Mo Maniruzzaman

UT Austin – Assistant Professor in Pharmaceutics and Drug Delivery

Presentation: 3D printing and state-of-the-art manufacturing techniques to advance drug delivery

Date: TBD

Dr Mohammed Maniruzzaman is currently an Assistant Professor in Pharmaceutics and Drug Delivery at College of Pharmacy, The University of Texas (UT) at Austin and leads the newly established state-of-the-art ‘Pharmaceutical Engineering and 3D Printing (PharmE3D)’ and ‘3D Printing and Bioprinting (3DpBio)’ Labs at UT Austin. Prior to this, he was appointed as a Lecturer in Pharmaceutics at the University of Sussex, UK. He obtained a PhD from the University of Greenwich with no corrections (RDC/12/M-3/14, UoG) and two accompanying awards including the Vice Chancellor’s Award in 2013 for the outstanding performance in his doctoral research. In addition, he has received 11 prestigious awards and scholarship for the outstanding academic performances including gold medals, ORSAS fellowship, and Rising STARs Award.

Dr Maniruzzaman has extensive research experience in pharmaceutical technology, drug delivery, additive manufacturing (e.g. 3D printing), medical implants and formulation engineering. This is reflected by authorship of more than 50 published papers (in ACS, RSC, and AAPS journals), 3 books, and more than 40 conference presentations in the relevant subject matters. Dr Maniruzzaman has chaired 6 scientific sessions in various international conferences and delivered more than 20 oral presentations including 8 invited lectures. His research into pharmaceutical technology/process engineering has recently resulted in 3 patented platform technologies of solid dispersions/granulations and salt manufacturing of poorly water soluble drugs with another 5 pending patent applications. Dr Maniruzzaman has edited a book on ‘3D and 4D printing in biomedical applications: process engineering and additive manufacturing’ for Wiley (ISBN 9783527344437). He has also recently edited 5 special issues on different aspects of continuous manufacturing, process engineering and 3D printing. Dr Maniruzzaman has secured funding to conduct leading-edge research in 3D printed pharmaceutical dosage forms (i.e. tablets, capsules), process engineering and manufacturing of pharmaceutical formulations, and medical devices (i.e. hybrid bandage) with a grant value in excess of USD 1.75M since 2018 with contracts for another 3 proposals currently being negotiated (grant value > USD 1.0M).

REGISTER NOW


Jim Marjeram

O’Hara Tech – Technology Director

Presentation: Advantages of Continuous Tablet Coating

Date: September 8th

Jim Marjeram is a graduate of Humber College with a specialty in Electro-Mechanical Engineering Technology. Jim has worked in the pharmaceutical industry for more than 30 years, concentrating on solid dosage solutions. Most of Jim’s career has been with O’Hara Technologies Inc. which has grown from local engineering firm to world class supplier of engineered pharmaceutical tablet coating and process systems during Jim’s tenure with the organization. Jim has served the company in diverse roles from product development to his current role as Sales Director. Throughout that time Jim has developed several patents and patents-pending in the area of continuous tablet coating. Jim can be contacted at jim.marjeram@oharatech.com.

REGISTER NOW


Seth Forster

Merck – Associate Principle Scientist

Presentation: Long-Acting Implants: Design for Durable Drug Delivery

Date: August 4th

Seth Forster is an Associate Principal Scientist in the Pharmaceutical Commercialization Technology department of Merck Manufacturing Division, based in West Point, PA. He is focused on development and scale-up of novel pharmaceutical dosage forms and process technology, especially for long-acting drug-eluting implants and dry powder inhalers. Seth has a BS in Chemical Engineering from Purdue University and an MS in Pharmaceutics from Temple University. He has been developing pharmaceutical products since 2006.

REGISTER NOW


Dr. John Shelley

Schrodinger – Schrodinger Fellow

Presentation: Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling

Date: July 28th

John Shelley, PhD, has been a software developer and product manager at Schrödinger for approximately 20 years. John was promoted to Fellow based upon his work on software products for small-molecule drug design. Over the last 6 years his work has shifted to modeling related to drug formulation particularly structured solutions including liposomes, polymersomes and protein solutions.

REGISTER NOW


Andrea Browning

Schrodinger – Product Manager

Presentation: Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling

Date: July 28th

Andrea Browning is responsible for leading efforts related to polymeric materials simulation in Schrödinger Materials Science and joined Schrödinger in 2017. Prior to joining Schrödinger, she was a lead research engineer and project manager at The Boeing Company. She brings a decade of experience in connecting industrial, engineering problems to root materials issues and how simulations can be used to inform industrial decisions.

REGISTER NOW


Dr. Dedong Wu

Astrazeneca – Senior Scientist

Presentation: Improving Bioavailability by Prodrug Approach

Date: September 1st

Dedong Wu is a senior scientist in AstraZeneca Pharmaceutical Science to provide expertise in the areas of predictive pharmaceutics, drug substance form selection, preformulation, enabling formulation and drug delivery for both early-stage drug candidate design/assessment and commercial drug product development. He had worked in Bristol-Myers Squibb for 5 years before he joined Astrazeneca in 2005. Dedong Wu received his Ph.D. in physical chemistry and has published more than 80 scientific manuscripts.

REGISTER NOW


Chandra Kelley

Pfanstiehl – Director of Business Development

Presentation: Key Considerations in Accelerating Biopharma Formulation Development

Date: August 11th

Chandra Kelley has been the Director of Business Development at Pfanstiehl, Inc. since 2016, has more than twenty years of experience in the Biopharma industry and a BS in Biology from PLNU in San Diego.

REGISTER NOW


Dr. Feng Zhang

UT Austin – Assistant Professor in Pharmaceutics

Presentation: Hot-melt extrusion to prepare amorphous solid dispersions: key concepts and common misperceptions

Date: July 7th

Feng Zhang is an assistant professor at the University of Texas at Austin. He received his Ph.D. in pharmaceutics from the University of Texas at Austin. He worked in the industry for 14 years prior to joining the department of pharmaceutics at the University of Texas at Austin in 2014. He was the Director of Product Development at PharmaForm (now part of BioDuro) from 2007 to 2010 and Senior Scientist in the Formulation and Process development department at Gilead from 2011 to 2013. Zhang has been conducting research and product development using twin-screw extrusion process since 1994.

His principal research interest at UT Austin is in twin-screw extrusion processing for continuous granulation, bioavailability enhancement, and controlled release drug delivery. He is the editor of 2nd edition of “Pharmaceutical Extrusion Technology”, published in 2018. He has authored four book chapters on twin-screw extrusion process. He has published 60 peer-reviewed papers articles. He is also inventor on 12 issued patents covering a wide range of drug delivery systems. He serves on the editorial board of AAPS PharmSci Tech and North American editor for Journal of Drug Delivery Science and Technology.

REGISTER NOW


Dr. Raimar Loebenberg

University of Alberta – Professor, Pharmacy and Pharmaceutical Sciences

Presentation: Presentation title coming soon

Date: TBD

Dr. Löbenberg holds a BS in pharmacy from the Johannes Gutenberg-University in Mainz, Germany. He received his PhD in pharmaceutics from the Johann Wolfgang Goethe-University in Frankfurt in 1996 for his work in drug delivery using nanoparticles.
He joined the University of Alberta in 2000.
His research interests are in Biopharmaceutics to predict the oral performance of drugs and botanicals and inhalable nanoparticles to treat lung diseases like lung cancer, tuberculosis or leishmaniasis.
He is founder and director of the Drug Development and Innovation Centre at the University of Alberta.
He was president of the Canadian Society for Pharmaceutical Sciences 2014-2015
He is a member of the United States Pharmacopeia Dietary Supplement Expert Committee.
He is vice chair of the Specialty Committee of Traditional Chinese Medicine in Pharmaceutics of the World Foundation of Chinese Medicine Science.
He is a member of the Health Canada Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology.
He is a member of the Health Canada Scientific Advisory Committee on Opiate Abuse.

REGISTER NOW


Dr. Xiaohu Deng

Viracta – Sr. Vice President of Product Development

Presentation: Phase-appropriate CMC Strategies in Drug Product Development

Date: July 14th

Bio Coming Soon

Dr. Stephen Hoag

University of Maryland – Professor of Pharmaceutical Sciences

Presentation: Presentation title coming soon

Date: TBD

Bio Coming Soon

Dr. Yi-Ling Hsieh

Allergan – Senior Scientist

Presentation: Presentation title coming soon

Date: TBD
Dr. Yi-Ling Hsieh is a Senior Scientist in Early Development in AbbVie. She has extensive experience in formulation development for early and late stage projects. She currently leads the lipid-based formulation platform development in AbbVie (Legacy Allergan) and investigates the impact of formulation design on biopharmaceutics. Prior to her current position, she led the solid-state characterization effort for the small and large molecule inhalation formulation in Novartis to support the development activities from pre-clinical stage to NDA submission. She also gained wide-ranging industry experience, including material characterization, novel enabling formulations, and regulatory quality compliance from her prior experience in Pfizer, Schering-Plough and Bristol-Myers Squibb. She authored several peer-reviewed publications with the focus of salt stability and the precipitation and supersaturation behavior of drug molecules. Dr. Hsieh earned her Ph.D. degree in Pharmaceutics and B.S. degree in Pharmaceutical Sciences from Purdue University – West Lafayette.